RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Comanche Biopharma

Comanche Biopharma

Develops an investigational siRNA medicine for preterm preeclampsia.

Latest funding

$75M Series B+ ·

Led by NEA · Source: startupintros.com

Latest round on record: Series B+, February 2025, amount undisclosed.

All 2 rounds ↓
X: @ComancheBio · 38 followers.
LinkedIn: linkedin.com.
Sectors: Biopharma, Biotechnology, Manufacturing, Pharmaceutical.
Stage: Series B+.
Based in: Concord, United States.
Founded: 2020.
Last round: Feb 26, 2025 · 628 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@ComancheBio · created May 1, 2023 (3 years old) · 38 followers
Website registeredJul 9, 2020 (6 years old)
TIMELINE · MONEY RAISED

Comanche Biopharma | 245 days from X account to first raise on record

@ComancheBio·Raised $75M in 1 sourced round·1 signal before the first raise
$19M$38M$56M$75MMAYNOVMAYNOVMAYNOVMAYNOV$75M||X ACCOUNT CREATED @COMANCHEBIO · MAY 1, 2023$75M Series B+ · Jan 1, 2024$75M B+ · JAN '24Series B+ · Feb 26, 2025B+ · FEB '25

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+undisclosed—startupintros.com
Series B+$75MNNEAstartupintros.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Similar Health and bio companies

Other companies backed by NEA

NEA portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/comanche-biopharma (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy